Abiy Agiro, PhD

Director
AstraZeneca Payer Evidence

Presentation(s):

• L-2C - The Prevalence of Hyperkalemia and Associated Clinical Characteristics and Outcomes Among Hospitalized COVID-19 Patients

  Monday, August 23, 2021
  6:30 PM – 7:30 PM US Eastern Time